StockGuide AI
Track Stocks
EN RU ES
Humana

Humana

Price: 368.69

Company and Business Model

Humana Inc. is a healthcare company that provides health insurance and related services. Its core products include Medicare Advantage plans, Medicaid services, and individual and group health insurance plans. Major business segments consist of Retail, Group and Specialty, and Healthcare Services. The primary revenue sources are premiums from health insurance policies and government contracts for Medicare and Medicaid services.

Investment Profile

Humana's stock is positioned for balanced investors, offering moderate growth potential alongside a dividend yield. The company's stable revenue growth and consistent earnings performance suggest a reliable investment profile. It may appeal to those seeking a combination of capital appreciation and income generation.

Official website

Fundamental metrics (experimental)

EPS (TTM) — earnings per share for the last 12 months, $
9.38 OK
Revenue QoQ — quarter-over-quarter revenue growth
21.9% ↑
EPS surprise
3.4% in line
20d volatility
2.5% stable
Dividend yield
1.2% moderate last ex-date: 2026-06-26
FMP / FinFeed data updated: 2026-06-11

Forecast impact

limited
Target Raised · Mizuho Securities · valid until 2026-07-08 · updated 2026-06-11
Target +7.0% target fill 93.4%
Reaction D5 pending · D10 pending fresh confirmed · market trust
Impact Potential 0 · Risk 0 price close to target
Reco: Buy Potential: 75 Risk: 30 Updated: 2026-06-11 05:36
How recommendation works
Why AI thinks so:
Strong momentum and solid fundamentals support growth outlook.

Track in portfolio

Price chart

AI recommendation Analyst forecast Calendar event Positive signal Negative signal Neutral / update Hold / informational B My buy S My sell
AI recommendation changes
Date Before After Reason
2026-05-24 02:41 Hold Buy Strong growth and positive momentum support bullish outlook.
2026-05-16 02:41 Buy Hold Strong momentum and solid earnings growth support bullish outlook.
2026-05-08 15:14 — Buy Strong fundamentals and positive momentum support growth outlook.
Analyst forecasts
Date Analyst Action Target Price Then
2026-06-08 11:27 Mizuho Securities Target Raised 335 → 390 350.08
2026-06-04 11:50 Morgan Stanley Target Raised 217 → 249 327.54
2026-06-03 11:35 Bernstein Target Raised 288 → 425 320.88
Cigna Elevance UnitedHealth Humana

Аналитики Barclays отмечают позитивные результаты крупных страховых компаний в первом квартале, но предупреждают о рисках во втором квартале

05/05/2026, 04:35 AM business forecast Аналитики: Barclays finance Cigna Elevance UnitedHealth Humana
В начале 2026 года крупные медицинские страховщики, такие как UnitedHealth, Elevance, Cigna и Humana, продемонстрировали обнадеживающие результаты за первый квартал, что положительно сказалось на настроениях инвесторов.
UnitedHealth Humana CVS Health

Администрация Трампа утвердила увеличение выплат Medicare Advantage на 2,48%, что положительно сказалось на акциях страховых компаний

04/06/2026, 03:33 PM business review healthcare UnitedHealth Humana CVS Health
Администрация Трампа в понедельник утвердила увеличение ставки выплат для частных планов Medicare на 2027 год, которое оказалось значительно выше первоначально предложенного.
UnitedHealth Humana CVS Health

Акции Humana (HUM), CVS Health (CVS) и UnitedHealth Group (UNH) упали после предложения администрации Трампа сохранить ставки Medicare Advantage на уровне прошлого года

01/27/2026, 06:33 AM business stock_drop healthcare UnitedHealth Humana CVS Health
Акции крупных компаний в сфере здравоохранения резко упали во вторник после того, как администрация Трампа предложила почти нулевые ставки для страховщиков Medicare Advantage.